Segantii Capital Management’s Pfizer PFE Stock Holding History

Segantii Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-326,936	Closed	-$11.8M	–	542
2021 Q1	$11.8M	Buy	326,936 +36,936	+13%	+$1.31M	0.51%	50
2020 Q4	$10.7M	Buy	+290,000	New	+$10.6M	0.49%	44
2017 Q4	–	Sell	-63,240	Closed	-$2.14M	–	52
2017 Q3	$2.14M	Hold	63,240	–	–	0.84%	27
2017 Q2	$2.02M	Hold	63,240	–	–	0.49%	30
2017 Q1	$2.05M	Hold	63,240	–	–	0.34%	36
2016 Q4	$1.95M	Buy	+63,240	New	+$1.93M	0.54%	26

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Segantii Capital Management's PFE Position: Q2 2021 in Review

Segantii Capital Management sold out of Pfizer (PFE) in Q2 2021, closing a stake of 326,936 shares — an estimated $11.8M sold.

Segantii Capital Management first reported a position in PFE in Q4 2016 and held it in 6 quarters. The position peaked at $11.8M in Q1 2021. 2,735 funds tracked by Wall St. Rank hold PFE as of Q2 2021.

Segantii Capital Management reported no remaining Pfizer position as of Q2 2021 after selling out during the quarter.
Segantii Capital Management sold 326,936 Pfizer shares in Q2 2021, an estimated $11.8M.
Segantii Capital Management first reported a position in Pfizer in Q4 2016 and held it in 6 quarters.
Segantii Capital Management's Pfizer position peaked at $11.8M in Q1 2021.
2,735 funds tracked by Wall St. Rank held Pfizer as of Q2 2021.

Based on Segantii Capital Management's 13F filing for Q2 2021, filed 6 Aug 2021.